Status:
COMPLETED
Interaction Study SLV337/Simvastatin
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
To investigate the effect of multiple doses of SLV337 on the pharmacokinetics of simvastatin and simvastatin acid when co-administered in healthy male subjects
Eligibility Criteria
Inclusion
- Volunteers with Body Mass Index 18.0-28.0 kg/m2
Exclusion
- Clinically relevant medical history
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00924430
Start Date
June 1 2009
End Date
July 1 2009
Last Update
September 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 1
London, United Kingdom